Related by context. All words. (Click for frequent words.) 72 smoldering myeloma 71 relapsed MM 70 antiretroviral naïve 70 myelodysplastic myeloproliferative diseases 70 recurrent glioblastoma multiforme 70 reduce serum phosphate 70 grade cervical dysplasia 70 HBeAg negative 69 refractory chronic lymphocytic 69 AA Amyloidosis 69 Ribavirin causes 69 Naive Patients 69 hyperphenylalaninemia HPA due 69 Amgen Neulasta R 69 severe hypercholesterolemia 69 relapsing remitting MS RRMS 69 SJIA 69 chronic thromboembolic pulmonary 69 HIV HCV coinfected 69 nonalcoholic steatohepatitis NASH 68 psoriatic arthritis PsA 68 stage IIIb IV 68 CTAP# Capsules 68 hepatorenal syndrome 68 colorectal liver metastases 68 diabetic kidney 68 BCG refractory carcinoma 68 haematologic 68 rheumatoid arthritis osteoarthritis ankylosing 68 alpha1 antitrypsin deficiency 68 acetonide FA 68 kidney urologic 68 Atypical Hemolytic Uremic Syndrome 68 Patients Treated With 68 unfavorable cytogenetics 68 either acutely decompensated 68 PLX STROKE targeting 67 unresectable tumors 67 deep venous thromboses 67 decompensated liver disease 67 pediatric malignancies 67 CYT# potent vascular disrupting 67 receiving immunosuppressive therapy 67 TNF antagonist 67 Hepatocellular Carcinoma HCC 67 receiving XGEVA 67 hematopoietic cancers 67 HeFH 67 ® lenalidomide 67 thetreatment 67 mitoxantrone plus 67 grade cervical intraepithelial 67 hypereosinophilic syndrome 67 hypokalemia hypomagnesemia 67 atypical hemolytic uremic syndrome 67 dirucotide MBP# 67 ZOLINZA 67 minimally symptomatic 67 refractory Hodgkin 67 moderate renal impairment 67 exocrine pancreatic insufficiency EPI 67 tumors GIST 67 metastatic carcinoid 67 metastatic pancreatic 67 homozygous familial hypercholesterolemia 67 refractory colorectal cancer 66 R lenalidomide 66 antiphospholipid syndrome 66 metastatic renal 66 metastatic bladder 66 ACTEMRA TM 66 Acute Myeloid Leukaemia AML 66 Xelox 66 mRCC 66 receiving VELCADE 66 Amgen Neulasta ® 66 relapsed leukemia 66 oral antidiabetic medication 66 peritumoral brain edema 66 metastatic GIST 66 Severe Primary IGFD 66 Myelodysplastic Syndrome MDS 66 Glioblastoma Multiforme GBM 66 invasive candidiasis 66 opioid induced constipation OIC 66 ribavirin therapy 66 metastatic malignant melanoma 66 eosinophilic asthma 66 hyperplasia BPH 66 overt nephropathy 66 LHRH receptor positive 66 Relapsing Remitting Multiple Sclerosis 66 biliary tract cancer 66 patientswith 66 de novo kidney transplant 66 parathyroid carcinoma 66 mild renal insufficiency 66 anthracycline taxane 66 CIMZIA TM certolizumab pegol 66 vascular occlusive diseases 66 Hodgkin lymphoma HL 66 patients coinfected 66 Certolizumab pegol 66 IMiDs ® compound 66 Investigational Treatment 66 neovascular diseases 66 pretransplant 66 sorafenib tablets 66 metastatic malignant 66 anthracycline containing 66 Hurthle cell 66 recurrent glioblastoma 66 non splenectomized 66 chronic ITP patients 66 acute mania 66 secondary hyperparathyroidism 66 bone marrow reticulin deposition 66 LymphoStat B belimumab 66 completely resected 66 AGHD 66 number NCT# ClinicalTrials.gov 66 NMIBC 66 Major Depressive Disorder MDD 66 HIV coinfected 66 AGILECT R 66 recurrent NSCLC 66 intravesical therapy 66 anagrelide 66 primary immunodeficiency PI 66 invasive lobular carcinoma 66 deCODE ProstateCancer TM 66 Dementia Related Psychosis 66 metastatic colorectal carcinoma 66 chronic myocardial ischemia 66 leukemia AML 66 recurrent metastatic 66 Acute Exacerbations 66 recurrent bladder 66 Heterozygous Familial Hypercholesterolemia 65 candidemia 65 Refractory Hodgkin Lymphoma 65 Chronic lymphocytic leukemia 65 naïve HCV 65 metastatic dermatofibrosarcoma protuberans DFSP 65 hypercholesterolemic patients 65 Fanconi syndrome 65 Alessandro Riva 65 lenalidomide Revlimid R 65 HER2 overexpression 65 nicardipine 65 constipation OIC 65 included exfoliative dermatitis 65 cystic fibrosis chronic pancreatitis 65 Femara letrozole 65 polycythemia vera essential thrombocythemia 65 resistant hormone refractory 65 Adjuvant chemotherapy 65 myocardial infarction ventricular fibrillation 65 EGFR mutation positive 65 sJIA 65 primary hyperparathyroidism 65 metastatic gastric 65 primary humoral immunodeficiency 65 immune thrombocytopenic purpura 65 MAGE A3 ASCI 65 grade glioma 65 rheumatoid arthritis psoriatic arthritis 65 systemic invasive fungal 65 resectable pancreatic cancer 65 TTR amyloidosis 65 bacterial prostatitis 65 nephropathic cystinosis cystinosis 65 refractory NSCLC 65 Acute Myelogenous Leukemia AML 65 nucleoside naive 65 acute GvHD 65 taxane refractory 65 ZACTIMA TM ZD# 65 weekly subcutaneous injections 65 tumor lysis syndrome 65 myelodysplastic syndrome MDS 65 recurrent metastatic ovarian cancer 65 erythema nodosum 65 M# rationally 65 retinal vein occlusion induced 65 autoantibody positive 65 de novo AML 65 concomitant cardiac 65 muscular dystrophy cystic fibrosis 65 arthritis PsA 65 Myelodysplastic Syndrome 65 advanced metastatic renal 65 heparin induced thrombocytopenia 65 C1 INH deficiency 65 K ras mutations 65 Newly Diagnosed Multiple Myeloma 65 hematological malignancy 65 Letairis ambrisentan 65 alemtuzumab treated 65 FUSILEV enhances 65 R sorafenib tablets 65 Progressive Multifocal Leukoencephalopathy 65 unresectable recurrent 65 diabetes mellitus DM 65 atypical Hemolytic Uremic Syndrome 65 chronic eosinophilic leukemia 65 subependymal giant cell 65 Hyperphosphatemia 65 Vitrasert R 65 CINQUIL 65 SIADH 65 PAOD 65 carotid artery blockage 65 Clinically significant 65 overactive bladder syndrome 65 relapsed SCLC 65 severe malignant osteopetrosis 65 known sulfonamide allergy 65 Peginterferon alfa 2b 65 galiximab 65 calcineurin inhibitor 65 indolent follicular non 65 Idiopathic Pulmonary Fibrosis 65 Angiotensin receptor blockers 65 toenail onychomycosis 65 prospectively enrolled 65 Helicobacter pylori eradication 65 lumiliximab 65 Antitumor Activity 65 delivers fluocinolone acetonide FA 65 esophageal candidiasis 65 lymphomas leukemias 65 hemorrhagic cystitis 65 Achieves Primary Endpoint 65 lupus erythematosus 65 unstable angina UA 65 relapsed ALL 65 hepatic metastases 65 CTAP# 65 choroidal vasculopathy 65 allogeneic HSCT 65 elevated ALT 65 grade squamous intraepithelial 65 Renal Cell Carcinoma RCC 65 Soft Tissue Sarcoma 65 Waldenstrom macroglobulinemia 65 myelogenous leukemia 65 relapsed Acute Myeloid 64 commercialize deforolimus 64 TNF alpha antagonist 64 oropharyngeal candidiasis OPC 64 neutropenic sepsis 64 anthracyclines taxanes 64 Oral corticosteroids 64 Cloretazine 64 AML MDS 64 differentiated thyroid 64 achieved CCyR 64 MDS MPD 64 BR.# 64 Juvenile Idiopathic Arthritis 64 Natalizumab 64 Relapsing remitting MS 64 Chronic Heart Failure 64 chronic idiopathic thrombocytopenic purpura 64 Dosa suffers 64 induce orthostatic hypotension 64 ALN HPN 64 maximally tolerated lipid lowering 64 convulsive disorders 64 morphometric vertebral fractures 64 opioid naive 64 Adenomas 64 trastuzumab Herceptin ® 64 Acute Renal Failure 64 non metastatic osteosarcoma 64 ADPKD 64 Follicular Lymphoma 64 Squamous 64 gastric carcinoma 64 recombinant PSMA vaccine 64 obstructive coronary artery 64 Lymphocytic 64 TMP SMX 64 immune thrombocytopenic purpura ITP 64 Meets Primary Endpoint 64 infliximab monotherapy 64 hypercholesterolaemia 64 active ankylosing spondylitis 64 renal insufficiency 64 PREZISTA r 64 postoperative AF 64 essential thrombocythemia ET 64 adalimumab Humira 64 T1c 64 alfa 2a 64 stratifying patients 64 corticosteroid dose 64 BENICAR HCT 64 elevated triglyceride levels 64 atherothrombosis 64 humanised monoclonal antibody 64 severe renal impairment 64 posterior uveitis 64 vWD 64 ATACAND 64 Aflibercept 64 cytomegalovirus infection 64 forodesine 64 discontinued Viread 64 oral nucleoside analogue 64 FOLFOX6 chemotherapy regimen 64 severe exacerbations 64 receptor tyrosine kinase inhibitor 64 oxypurinol 64 lupus renal disease 64 IOP lowering 64 Folfox 64 deletion 5q 64 hemodynamically unstable 64 antiplatelet medications 64 Familial Hypercholesterolemia 64 ANCA associated 64 Glioblastoma Multiforme 64 unresectable malignant mesothelioma UMM 64 hypercalcemia 64 taxotere 64 systemic juvenile idiopathic 64 colorectal cancer liver metastases 64 acyclovir Lauriad R 64 rituximab refractory follicular 64 Cardiotoxicity 64 SHPT 64 refractory metastatic 64 neurogenic bladder 64 Lung transplantation 64 metastatic HRPC 64 Demonstrates Positive 64 Renal Impairment 64 renal failure interstitial lung 64 pancreatic insufficiency 64 achieved ACR# 64 lintuzumab SGN 64 Safinamide 64 Phase Ib IIa 64 evaluating tivozanib 64 carcinoid tumors 64 situ CIS 64 IBS C 64 chronic HBV 64 invasive aspergillosis 64 venous thromboembolic disease 64 adult chronic ITP 64 Mg Usa 64 primary hypercholesterolemia 64 tuberous sclerosis TS 64 bronchopulmonary dysplasia BPD 64 bladder ovarian 64 STRIDE PD 64 hereditary deficiency 64 chronic renal disease 64 pulmonary artery hypertension 64 Diabetic Macular Edema 64 BEXXAR Therapeutic Regimen 64 riociguat 64 neuroendocrine cancers 64 Hormone Refractory Prostate Cancer 64 baminercept 64 Reminyl galantamine 64 bronchial hyperresponsiveness 64 Philadelphia Chromosome Positive 64 recurrent glioblastoma multiforme GBM 64 docetaxel Taxotere ® 64 metabolic alkalosis 64 ritonavir boosted protease inhibitor 64 inadequate glycemic 64 chronically immunosuppressed solid 64 GERD migraine headaches 64 mildly symptomatic 64 metastatic renal cell 64 benign prostatic hypertrophy 64 somatostatin analog 64 diffuse gastric 64 IMiDs ® 64 Erythropoietic therapies may 64 radiotherapy RT 64 peritoneal carcinomatosis 64 Relapsed Refractory 64 adverse cytogenetics 64 Occlusive Disease 64 LPLD 63 develop HBV reactivation 63 Plaquenil 63 NIASPAN 63 carcinoid syndrome 63 treating neuropathic pain 63 endocrine therapies 63 Stage IIB 63 proliferative diabetic retinopathy 63 postoperative pulmonary 63 steroid refractory GvHD 63 non hodgkin lymphoma 63 oral ridaforolimus 63 BARACLUDE ® 63 dermatologic reactions 63 dose intramuscular 63 Cimzia TM 63 AA amyloidosis 63 Pegloticase 63 moderately emetogenic 63 Bronchiectasis 63 variceal bleeding 63 immunomodulatory therapy 63 antibody MAb 63 aplastic anemia AA 63 gastrointestinal mucositis 63 deCODE AF TM 63 CALGB # [002] 63 histologically confirmed 63 PEGINTRON TM 63 purpura ITP 63 cytopenias 63 Octreolin 63 RhuDex ™ 63 Severe Sepsis 63 CIMZIA ™ 63 Genasense ® 63 β blocker 63 castrate resistant prostate cancer 63 serum phosphate 63 papillary renal cell carcinoma 63 Nonspecific 63 Paroxysmal Nocturnal Hemoglobinuria PNH 63 Chronic Myelogenous Leukemia CML 63 macular edema secondary 63 XL# anticancer compounds 63 CYT# QbG# 63 FOLFOX6 63 diabetic gastroparesis 63 steroid refractory ulcerative 63 assessing T DM1 63 aerosolized AAT 63 Kinoid 63 decompensated cirrhosis 63 containing abacavir 63 FluCAM arm 63 Nonalcoholic fatty liver 63 unresectable locally advanced 63 bronchogenic carcinoma 63 dalteparin 63 relapsed refractory multiple myeloma 63 Golimumab 63 Noxafil 63 Bayer HealthCare Onyx Pharmaceuticals 63 basal cell carcinoma BCC 63 Bezielle 63 thromboembolic complications 63 Ankylosing spondylitis 63 tumor histology 63 cytomegalovirus retinitis 63 recurrent DVT 63 Triapine R 63 TO AVOID PREGNANCY WHILE 63 adrenocortical cancer 63 RhuDex TM 63 vitreoretinal disorders 63 Adjunctive 63 INVEGA ® 63 progressive dyspnea 63 histologic subtype 63 sapacitabine CYC# 63 sulfonylurea metformin 63 biologic antibody 63 unresectable HCC 63 methotrexate monotherapy 63 ritonavir boosted 63 Acute myeloid leukemia 63 chronic myeloid 63 Warfarin Coumadin 63 Microalbuminuria 63 dopaminergic therapy 63 R Saizen R 63 hematological cancers notably 63 herpes zoster shingles 63 Initiate Clinical Trial 63 Oral Fingolimod 63 HGS ETR1 mapatumumab 63 oropharyngeal candidiasis 63 painful diabetic neuropathy 63 carcinoma HCC 63 Brentuximab Vedotin SGN 63 gastrointestinal stromal tumor GIST 63 grade gliomas 63 CTEPH 63 unresectable stage 63 chronic immune thrombocytopenic 63 Idiopathic pulmonary fibrosis 63 metastatic neuroendocrine tumors 63 Nilotinib 63 TMS Therapy 63 Patients Receiving 63 elevated serum creatinine 63 severe gastroparesis 63 metastatic colorectal 63 peripheral arterial occlusive disease 63 spontaneous bacterial peritonitis 63 proliferative retinopathy 63 nonnucleoside reverse transcriptase inhibitors 63 idiopathic thrombocytopenic purpura ITP 63 systemic anaplastic large 63 headache abdominal pain 63 postoperative chemotherapy 63 miconazole Lauriad ® 63 leukemia multiple myeloma 63 pancreatic neuroendocrine tumors 63 Aryplase 63 Pelvic inflammatory 63 liver metastasis 63 Glioblastoma multiforme GBM 63 Nesiritide 63 Aptivus ® 63 IV NSCLC 63 orally administered inhibitor 63 stage IIIB 63 Liver transplantation 63 Deforolimus 63 evaluating mipomersen 63 artery stenosis 63 genotypic resistance 63 TNF Tumor Necrosis Factor 63 cisplatin chemotherapy 63 plus prednisone prednisolone 63 Intravenous immunoglobulin 63 orally inhaled migraine 63 ergot derivatives 63 Recombinant interferon alpha 63 chemoradiation therapy 63 demonstrated antitumor activity 63 baseline LDH 63 NATRECOR ® 63 oral FTY# 63 Pulmonary hypertension 63 dopamine partial agonist 63 pheochromocytoma 63 Tolvaptan 63 moderate hepatic impairment 63 Vidaza ® 63 BrachySil TM 63 Fludara ® 63 mycophenolic acid 63 retinopathy nephropathy 63 PCNSL 63 alpha1 antitrypsin AAT deficiency 63 Initiates Phase III 63 rheumatoid arthritis inflammatory bowel 63 SPRYCEL ® 63 genotype 1b 63 Atomoxetine 63 Cojocaru correspondent 63 Adenoviruses usually cause 63 Diabetic Retinopathy DR 63 latent tuberculosis infection 63 hypervascular tumors 63 relapsing multiple sclerosis 63 Phase #b/#a clinical 63 stable angina 63 systemic fungal infections 63 cladribine Cladribine Tablets 63 Campath alemtuzumab 63 multivessel coronary artery 63 acute peptic ulcer 63 aflibercept VEGF Trap 63 aspirin clopidogrel 63 chemotherapy cisplatin 63 phase IIb study 63 esophageal gastric 63 humanized interleukin 6 63 locoregional 63 Neovascular Age Related Macular 63 palifermin 63 AVASTIN 63 ß blockers 63 previously untreated follicular 63 pretest probability 63 haematological cancers 63 interferon ribavirin 63 potentially hepatotoxic 63 TASKi3 63 severe neutropenia 63 cirrhosis liver failure 63 Recurrent Glioblastoma 63 Pafuramidine 63 Myelofibrosis 63 vinca alkaloid 63 malignant ascites 63 evaluating T DM1 63 oxaliplatin Eloxatin 63 combining voreloxin 63 Cutaneous T 63 neutropenia dehydration dyspnea 63 induced macular edema 63 induced anemia 63 INCB# [003] 63 Zometa hazard 63 underwent surgical resection 63 sargramostim 63 multiple sclerosis lupus 63 Pulmonary Arterial Hypertension PAH 63 chronic HCV infection 63 advanced hepatocellular carcinoma 63 nonpharmacologic 63 Hyperuricemia 63 veno occlusive disease 63 neovascular glaucoma 63 pulmonary infiltrates 63 DEB# 63 erlotinib Tarceva ® 63 histologically proven 63 KRAS mutant tumors 63 severe hepatic dysfunction 63 Cariprazine 63 EXJADE 63 Venous thromboembolism 63 glycosylated hemoglobin levels 63 radiation chemoradiation 63 post thrombotic syndrome 63 postoperative delirium 63 novel VDA molecule 63 Temodar ® 63 Pharmacokinetics PK 63 dyslipidemia hypertension diabetes 63 antiretroviral naive 63 Acute myelogenous leukemia 62 isolated systolic hypertension 62 metastatic kidney 62 hyperphosphataemia 62 interferon alpha IFN 62 pulmonary hypertension PH 62 nosocomial pneumonia NP 62 pyridostigmine 62 beta blockers ACE inhibitors 62 recurrent malignant glioma 62 euthymic patients 62 refractory acute myeloid 62 Teriflunomide 62 vitreous floaters 62 undergone radical prostatectomy 62 TRIOLEX HE# APOPTONE HE# 62 CYP#A# substrate 62 GW# [003] 62 advanced adenomas 62 colorectal adenoma 62 heterozygous FH 62 alvespimycin 62 Lantus insulin 62 HMG CoA reductase inhibitors 62 NATRECOR R 62 hepatocellular carcinoma liver 62 Mitomycin C 62 familial hypercholesterolemia FH 62 thrombocytopenic 62 familial hypercholesterolemia 62 lactate dehydrogenase LDH 62 generation purine nucleoside 62 occlusive disease 62 unstable angina pectoris 62 rALLy 62 T2DM 62 Randomized Double blind 62 dual endothelin receptor antagonist 62 chronic GVHD 62 dose dexamethasone 62 symptomatic hyponatremia 62 prognostic indicators 62 sunitinib Sutent 62 liver scarring 62 hormone receptor negative 62 cSSSIs 62 Maribavir 62 esthesioneuroblastoma rare form 62 bladder carcinoma 62 Lambert Eaton Myasthenic 62 dose escalation phase 62 syncope fainting 62 Tasigna prolongs 62 pelvic malignancies 62 prospectively stratified 62 nonsmall cell lung cancer 62 teriflunomide 62 postoperative complication 62 polyp recurrence 62 Chronic Renal Failure 62 indolent NHL 62 Cloretazine ® 62 refractory gout 62 Acute Decompensated Heart Failure 62 approved incretin mimetic 62 intravenous cyclophosphamide 62 Rilonacept 62 NASH Huntington 62 DULERA 62 urethral stricture 62 CA9 SCAN 62 ACAPODENE TM 62 follicular lymphoma FL 62 oral talactoferrin 62 eculizumab therapy 62 coagulation abnormalities 62 pioglitazone HCl 62 lung pancreatic 62 medically refractory 62 KIACTA ™ 62 Avandia Actos 62 HBeAg + 62 Adjuvant Treatment 62 nonischemic 62 null responder HCV 62 Diamyd r 62 hypertension diabetes mellitus 62 treat chronic sinusitis 62 benign prostatic hypertrophy BPH 62 Gamunex C 62 Budesonide foam crofelemer 62 virus HCV infection 62 underwent resection 62 relapsed multiple myeloma 62 INSPIRE Trial Phase III 62 juvenile idiopathic arthritis JIA 62 BRAF inhibitor 62 Simulect 62 non cirrhotic portal 62 intravascular hemolysis 62 visceral metastases 62 im peramivir 62 FOR FURTHER INFORMATION ABOUT 62 intravenous RSD# 62 dasatinib Sprycel ® 62 antiarrhythmic drug 62 relapsed acute lymphoblastic 62 Abrupt discontinuation 62 ara C 62 salmeterol fluticasone 62 fallopian tube carcinoma 62 Azacitidine 62 transplantation HCT 62 Clot busting 62 juvenile myoclonic epilepsy 62 Reduces Mortality 62 Flu Cy 62 SGPT 62 Congenital Emphysema 62 Ragweed Allergy 62 FROVA 62 Edurant 62 Chronic myeloid leukemia 62 percutaneous cryoablation 62 headache nasopharyngitis 62 perioperatively 62 thromboembolic disease 62 systemic hypotension 62 Chronic Hepatitis C 62 ZACTIMA 62 deferiprone 62 p# biomarker 62 PEGylated Fab fragment 62 certolizumab 62 Leukemias 62 sapropterin dihydrochloride Tablets 62 terlipressin 62 pouchitis 62 torsade de pointes 62 pediatric Crohn disease 62 squamous histology 62 HER2 positive cancers 62 Lupus Nephritis 62 alendronate Fosamax 62 gastrointestinal GI motility disorders 62 allogeneic hematopoietic stem cell 62 glucocorticoid therapy 62 1 diabetes T1D 62 Primary Hypercholesterolemia 62 AVAPRO 62 Infusion Reactions Severe 62 Mantle Cell Lymphoma 62 nasopharyngitis headache 62 nilotinib Tasigna ® 62 intracranial hemorrhage ICH 62 SUSTENNA TM 62 vinorelbine tartrate 62 including eniluracil ADH 62 mycophenolate mofetil MMF 62 Kit CD# positive 62 thalidomide Thalomid 62 pancreatic NET 62 Cinquil 62 nucleotide analogue 62 Non inferiority 62 Balamuthia 62 everolimus eluting stents 62 SNT MC# 62 PNP inhibitor 62 HER2 expression 62 UA NSTEMI 62 ARCALYST ® 62 Pseudomonas aeruginosa infections 62 venous stasis ulcers 62 Enzastaurin 62 capecitabine Xeloda 62 hypophosphatemia 62 treatment naive genotype 62 portal vein thrombosis 62 Raptiva r 62 oral Hycamtin 62 B Cell Lymphoma 62 midstage clinical 62 Zorbtive TM 62 cinacalcet 62 hyperparathyroidism 62 rheumatoid arthritis RA psoriatic 62 INTEGRILIN R 62 Acute Coronary Syndromes ACS 62 canakinumab 62 humanized therapeutic 62 SIMPONI ® 62 Kepivance 62 Crohn disease CD 62 Rheumatoid Arthritis RA 62 serologically active systemic lupus 62 prostate cancer CaP 62 dose melphalan 62 Improves Outcomes 62 pericardial effusion 62 Hedgehog Pathway Inhibitor 62 gastrointestinal stromal tumor 62 Pagoclone 62 Fibrillex TM 62 Zevalin consolidation 62 HoFH 62 Celiac sprue 62 hormone refractory metastatic prostate 62 antidepressants fluoxetine 62 invasive fungal infections 62 chronic rheumatic 62 systemic corticosteroid 62 investigational FACTIVE intravenous formulation 62 trial evaluating PRX# 62 developing Bicifadine serotonin 62 rhIGF-I/rhIGFBP-3 62 Scheuermann kyphosis 62 systolic dysfunction 62 Nexavar sorafenib 62 MPS IVA 62 Tarceva TM 62 Chronic HCV 62 surgically resectable 62 PresbyLens ® 62 TAXOTERE ® 62 Lubiprostone 62 hepatic fibrosis 62 Eisenmenger syndrome 62 operable breast cancer 62 invasive fungal infection 62 HBV infections 62 Empatic ™ 62 extrapleural pneumonectomy 62 antiangiogenic therapy 62 refractory indolent non 62 Archexin 62 Platinol ® cisplatin 62 non constipating irritable 62 ruxolitinib 62 blood clot dissolving 62 Surgical resection 62 prostate carcinoma 62 Unstable Angina 62 cerebral angiography 62 pemphigus vulgaris 62 RRMS patients 62 SIMPONI TM 62 intra arterial chemotherapy 62 Diabetic Foot Ulcer 62 antithrombotic therapy 62 ENABLE Phase 2 62 PEGylated interferon beta 1a 62 osteoporotic vertebral compression fractures 62 ADVEXIN therapy 62 locoregional recurrence 62 IL# PE#QQR 62 Syncria R 62 PROCRIT ® 62 allogeneic bone marrow 62 anticholinergic agents 62 substantially excreted 62 dimebon latrepirdine 62 Motesanib 62 leukemia lymphoma multiple myeloma 62 systemic ALCL 62 dasatinib Sprycel 62 Temsirolimus 62 exocrine pancreatic insufficiency 62 dyslipidaemia 62 postmenopausal osteoporotic women 62 renal artery stenosis 62 adjuvant radiation 62 systolic hypertension 62 Morquio 62 Mg Uk 62 genitourinary GU 62 TNF inhibitor therapy 62 Advanced Melanoma 62 Velcade bortezomib 62 orchitis 62 RANK Ligand inhibitor 62 recurrent genital herpes 62 Zarnestra 62 nephropathic cystinosis 62 malignant pleural mesothelioma 62 albiglutide 62 Cell Non Hodgkin 62 abacavir lamivudine 62 syncopal episodes 62 Phenylketonuria PKU 62 lymphoid tumors 62 dexanabinol 62 Known hypersensitivity 62 myelofibrosis MF 62 Intravitreal 62 spinal metastases 62 Renal Cell Carcinoma 62 elevated LDL cholesterol 62 metaglidasen 62 demethylation agents 62 Lupus nephritis 62 Pegylated Interferon 62 thymectomy 62 BRIM2 62 octreotide implant 62 neuromuscular spasm 62 clevidipine 62 dose atorvastatin 62 elevated LDH 62 diarrhea predominant irritable 62 prednisone prednisolone plus 62 cytotoxic therapy 62 serum phosphorous 62 BCG refractory 62 Tumor Response 62 treating cancerous tumors 62 Bone marrow transplant 62 EGFr expressing metastatic colorectal 62 aromatase inhibitor therapy 62 congenital deficiency 62 obstructive coronary 62 postoperative atrial fibrillation 62 non resectable metastatic 62 myopic CNV 62 systemic lupus erythematosus psoriasis 62 Serostim ® 62 regorafenib 62 rFVIIa 62 ulcerative colitis Crohn disease 62 coinfected patients 62 CYP#A# CYP#D# 62 Panzem R 62 MGd 62 protease inhibitor PI 62 lupus nephritis 62 thoracoscopic lobectomy 62 preoperative chemotherapy 61 STELARA TM 61 GRNOPC1 contains 61 hemodialysis peritoneal dialysis 61 SinuNase TM 61 lumbar spinal stenosis LSS 61 Alequel 61 confidence interval #.#-#.# 61 thalassemia sickle cell 61 transarterial 61 sorafenib Nexavar 61 melphalan prednisone 61 decompensated heart failure 61 Genentech Rituxan 61 urothelial carcinoma 61 receiving TNF blockers 61 Sudhir Agrawal D.Phil 61 Diabetic Macular Edema DME 61 mismatched bone marrow 61 Hypertrophy 61 Telintra 61 aortic valve stenosis 61 methotrexate therapy 61 mg/m2 dose 61 liver histology 61 breast endometrial 61 LV dysfunction 61 advanced adenoma 61 Pfizer Camptosar 61 Oral NKTR 61 Chronic pancreatitis